In the current session, BioNTech Inc. (NASDAQ:BNTX) is trading at $108.38, after a 0.05% decrease. Over the past month, the stock fell by 13.84%, and in the past year, by 24.96%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio.
BioNTech P/E Ratio Analysis in Relation to Industry Peers
Compared to the aggregate P/E ratio of the 54.12 in the Biotechnology industry, BioNTech Inc. has a lower P/E ratio of 2.59. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
